Journal of Environmental and Public Health / 2012 / Article / Tab 2

Research Article

Association between Depressive Symptoms and Metabolic Syndrome in Police Officers: Results from Two Cross-Sectional Studies

Table 2

Mean levels and prevalence of metabolic syndrome by gender and geographic location.

Component cutpoint (must meet β‰₯1 of the cutpoints per component)PrevalenceMean (SD)
BuffaloSpokaneBuffaloSpokane
Metabolic syndrome componentMenWomenOverallMenWomenOverallMenWomenMenWomen
𝑁 %* 𝑁 %* 𝑁 %* 𝑁 %* 𝑁 %* 𝑁 %*( 𝑁 = 3 0 4 )( 𝑁 = 1 0 6 )( 𝑁 = 1 2 1 )( 𝑁 = 9 )

Abdominal obesity11337.21817.013132.04839.7555.65340.8
Waist circumference, cmβ‰₯102 Men, β‰₯88 Women99.3 (11.4)79.9 (11.5)100.3 (10.8)87.5 (9.9)
Elevated triglycerides11738.5 9 8.512630.75243.0333.35542.3
Triglycerides, mg/dLβ‰₯15011337.2 9 8.512228.65342.7330.05641.8153.8 (127.4)88.4 (130.0)157.6 (102.7)165.3 (150.6)
Self-reported fibrates or nicotinic acid medication, %Yes 6 2.0 1 0.9 7 1.7 5 4.10 0.0 5 3.8
Reduced HDL cholesterol14347.02826.417141.75343.8222.25542.3
HDL cholesterol, mg/dL<40 Men, <50 Women14246.72824.817040.05443.5220.05641.842.2 (12.0)58.3 (15.7)42.6 (12.4)56.0 (16.1)
Self-reported fibrates or nicotinic acid medication, %Yes 6 2.0 1 0.9 7 1.7 5 4.10 0.0 5 3.8
Glucose intolerance 8327.31211.3 9523.24638.0333.34937.7
Fasting glucose, mg/dLβ‰₯100 8126.61110.4 9221.94838.7330.05138.194.7 (14.0)86.4 (8.4)98.9 (10.7)93.4 (10.3)
Self-reported diabetes medication, %Yes 7 2.3 1 0.9 8 2.0 4 3.30 0.0 4 3.1
Hypertension12942.42725.515638.15545.5222.25743.9
Systolic blood pressure, mmHgβ‰₯130 6922.71817.0 8720.93729.8330.04029.9122.2 (11.3)116.7 (13.3)125.0 (10.3)121.8 (10.1)
Diastolic blood pressure, mmHgβ‰₯85 7926.01716.0 9623.33528.20 0.03526.178.7 (10.2)74.6 (9.6)81.1 (8.5)78.9 (4.7)
Self-reported hypertension with antihypertensive medication, %Yes 4514.8 7 6.6 5212.71714.00 0.01713.0
Number of components1.9 (1.4)0.9 (1.1)2.1 (1.4)1.7 (1.9)
0 5417.85350.010726.11411.6444.41813.9
1 7524.72523.610024.43226.5111.13325.4
2 7926.01917.9 9823.93024.8111.13123.9
3 4815.8 6 5.7 5413.22218.2111.12317.7
4 3210.5 2 1.9 34 8.31915.7111.12015.4
5 16 5.3 1 0.9 17 4.2 4 3.3111.1 5 3.9
Prevalence (β‰₯3) 9631.6 9 8.510525.64537.2333.34836.9

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.